A Randomized, Double-blind, Parallel-Controlled Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

Trial Profile

A Randomized, Double-blind, Parallel-Controlled Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

Recruiting
Phase of Trial: Phase III

Latest Information Update: 14 Sep 2016

At a glance

  • Drugs Pneumococcal 13 valent vaccine conjugate-Beijing-Minhai-Biotechnology (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate
  • Indications Pneumococcal infections
  • Focus Pharmacodynamics; Registrational
  • Most Recent Events

    • 31 Aug 2016 Planned End Date changed from 1 Oct 2016 to 1 Dec 2017.
    • 31 Aug 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Dec 2017.
    • 31 Aug 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top